Press



For press and media inquiries, please contact us at info@mspentechnologies.com.

About MS Pen

MS Pen Technologies, Inc. is a biotech company developing real-time tissue diagnostics to optimize medical decisions, surgical interventions, and treatment options for patients. The company’s debut technology is the MasSpec Pen System™, a bespoke mass spectrometry diagnostic platform capable of characterizing cancerous tissue — both in vivo and ex vivo — in just 10 seconds. The technology will save patients, surgeons, and hospital systems complications and financial burden.

FOUNDED

2019

PATENTS ISSUED

3

PATENTS ISSUED

3

Leadership
 

Justin Wiseman, Ph.D.
CEO


Livia Schiavinato Eberlin, Ph.D.
Co-Founder, Chief Scientific Officer


James W. Suliburk, M.D.
Co-Founder, Chief Medical Officer


Thomas E. Milner, Ph.D.
Co-Founder, Technology Advisor

Our inbox is always open

Request Info


If you are interested in learning more about MS Pen Technologies, our diagnostic platform, or investment and partnership opportunities, please feel free to reach out.